There is no charge or limit to enter the awards.

All nominees or co-nominees must be currently employed in a pharmaceutical, medical device, diagnostic or biotech company.

Entries will only be accepted from vendors, solution providers or consultants if the project they are entering is in association with a pharmaceutical, medical device, diagnostic or biotech company.

We will only accept projects within the time period of January 2023 – July 2025

Each category has specific criteria. 

Under each category, there is a list of bullet points which your project needs to demonstrate in the nominations form on the submission site. 

The short executive summary is 2000 characters. Please note that space counts towards your character limit. 

The longer project description is 4000 characters. Please note that space counts towards your character limit. 

Remember, you can use the supplementary information to include links to reports, articles etc which evidence your submission 

Yes. You can use an AI platform to work on an entry submission, however we require all entries to be reviewed by a human. If an AI platform has been used, please state this in the supplementary information field and confirm it has been reviewed and signed off before submission.

No, we accept submissions from organisations operating locally or globally. We accept submissions from companies based in any country in the world. 

Applications Open: 11th May 2025

Entry Submission Close: 18th July 2025

Shortlist Announcement: 18th August 2025

Finalists & Winners revealed: 14th - 21st November 2025

In 2025, there is no ceremony. Winners will feature in dedicated reports to showcase the winning projects. The reports will be shared to the Reuters Events Pharma database and on their social media channels.